Reviewing Eastgate Biotech Its Competitors
ETBIDelisted Stock | USD 0 0.00 0.00% |
Under 54% of Eastgate Biotech's investor base is interested to short. The analysis of current outlook of investing in Eastgate Biotech Corp suggests that many traders are impartial regarding Eastgate Biotech's prospects. Eastgate Biotech's investing sentiment shows overall attitude of investors towards Eastgate Biotech Corp.
Eastgate |
Eastgate Biotech is one of 352 publicly-traded companies in the Biotechnology industry, but how does it weigh in compared to its peers We will compare Eastgate Biotech to related companies based on the strength of its institutional ownership, valuation, earnings, analyst recommendations, dividends, risk and profitability. Profitability This table compares
Read at thelincolnianonline.com
Eastgate Biotech Fundamental Analysis
We analyze Eastgate Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eastgate Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eastgate Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Eastgate Biotech is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Eastgate Biotech Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eastgate Biotech stock to make a market-neutral strategy. Peer analysis of Eastgate Biotech could also be used in its relative valuation, which is a method of valuing Eastgate Biotech by comparing valuation metrics with similar companies.
Peers
Eastgate Biotech Related Equities
AMKR | Amkor Technology | 2.42 | ||||
MRAM | Everspin Technologies | 1.24 | ||||
IPGP | IPG Photonics | 0.50 | ||||
UMC | United Microelectronics | 0.46 | ||||
BKH | Black Hills | 0.03 | ||||
NTES | NetEase | 0.64 | ||||
CLILF | CapitaLand Investment | 1.49 | ||||
ALNT | Allient | 1.54 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Eastgate Stock
If you are still planning to invest in Eastgate Biotech Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eastgate Biotech's history and understand the potential risks before investing.
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |